NumFin

Abiomed, Inc.

Simbolis: ABMD

NASDAQ

381.02

USD

Rinkos kaina šiandien

  • 126.8485

    P/E santykis

  • -5.7181

    PEG koeficientas

  • 17.18B

    MRK kapitalizacija

  • 0.00%

    DIV pajamingumas

Abiomed, Inc. (ABMD) Finansinės ataskaitos

Download
MetinisKetvirtinis
LinijinisLoginis
Diagramoje matote numatytuosius skaičius dinamikoje Abiomed, Inc. (ABMD). Įmonės pajamos rodo NaN M vidurkį, kuris yra NaN % gowth. Vidutinis viso laikotarpio bendrasis pelnas yra NaN M, kuris yra NaN %. Vidutinis bendrojo pelno rodiklis yra NaN %. Įmonės praėjusių metų veiklos grynojo pelno augimas yra NaN %, kuris lygus NaN % % vidutiniškai per visą bendrovės istoriją.,

MetinisKetvirtinis
10Y20Y30Y40Y

Balansas

Pasinerdami į Abiomed, Inc. fiskalinę trajektoriją, stebime vidutinį turto augimą. Įdomu tai, kad šis rodiklis yra , atspindintis tiek aukščiausias, tiek žemiausias įmonės rodiklius. Palyginus per ketvirtį, šis skaičius pakoreguojamas iki . Žvilgtelėjus į praėjusius metus, matyti, kad bendras turto pokytis yra NaN. Akcininkų vertė, kurią parodo bendras akcininkų nuosavas kapitalas, vertinama pagal NaN ataskaitine valiuta. Šio aspekto pokytis per metus yra NaN%.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990198919881987

balance-sheet.row.cash-and-short-term-investments

3092.52758.6583.7443.1
491.7
362.2
229.9
212.1
132
76.6
76.7
77.2
60.3
58.3
57.2
38.3
75.1
30.8
41.5
27.3
54.4
71.3
92.5
106.4
18.2
26.4
9.4
10.6
0.6
0.5
0.7
4.7
8.1
24.6
10.4
13.3
2.4

balance-sheet.row.short-term-investments

2452.62625.8351250.8
370.7
319.3
190.9
163.8
109.6
55.7
67.3
71.2
54.5
53.5
55.4
36.3
5.5
23
33.9
20.4
9.9
25.7
2
4.5
8.9
23.7
7.7
7.7
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

365.1490.697.284.7
90.8
70
54.1
42.8
31.8
24.4
22.9
20.5
15.4
13.5
15.7
14.1
10.9
8.9
8.6
6
5.4
7.3
10
6.7
6.4
5.4
4.8
2.6
1.8
1.7
0.8
0.6
0.7
0.7
0.8
0.5
0.2

balance-sheet.row.inventory

381.799481.190.1
80.9
50.2
34.9
26.7
16.8
13.9
14.9
11.1
7.5
9.2
14.8
17.4
8.6
4.9
3.9
2.7
2.9
4.2
3.7
3.5
2.9
2.3
1.8
1.7
1.4
2.2
1.5
0.9
1.2
1.1
0.9
0.6
0.4

balance-sheet.row.other-current-assets

145.1933.32618
13.7
11.8
8
6.8
39.6
3.1
2
1.7
1.5
1.7
0.8
1.7
1.8
1.9
1.2
1
0.9
0.8
0.8
0.5
0.3
0.2
0.2
0.1
3.9
2.7
9
13.8
14
0.2
0.1
0
0.4

balance-sheet.row.total-current-assets

3984.64976.5788635.9
677.2
494.3
327
288.4
220.1
118
116.6
110.5
84.7
82.7
88.5
71.5
96.4
46.4
55.2
37
63.6
83.7
107
117.1
27.8
34.3
16.2
15
7.7
7.1
12
20
24
26.6
12.2
14.4
3.4

balance-sheet.row.property-plant-equipment-net

827.51212203.2176.7
145
117.2
87.8
23.2
9.1
6.9
6.5
6.4
6.3
6.8
7.8
7.6
5.8
4.8
2.8
3.2
4
4.7
4.8
4
3.9
3.7
1.9
0.6
0.5
0.6
0.7
0.6
1.1
1.1
0.3
0.3
0.3

balance-sheet.row.goodwill

302.0576.878.632
32.6
35.8
31
33
31.5
38
35.4
36.8
38.9
37.2
31.3
31.6
26.7
19.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

190.6345.647.522.6
15.2
16.7
14.5
15.4
14.7
0
0
0.1
1.6
3
4.4
6.9
7.3
8.2
0.9
0.8
0.7
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0.3
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

492.68122.412654.5
47.8
52.5
45.5
48.4
46.2
38
35.4
37
40.6
40.1
35.7
38.5
34
27.3
0.9
0.8
0.7
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0.3
0
0
0
0

balance-sheet.row.long-term-investments

1311.42351.9365.7302.2
21.7
37.5
47.1
1
14
41.8
11.4
0
0
0
3.7
0
0
0
2.1
18.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

50.2110.611.443.3
77.5
70.7
34.7
58.5
45.2
0
0
0
0
0
0
0
0
0.3
-2.1
-18.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0003.8
85.1
14.2
8.3
4.4
3.7
0.8
0
0
0
0
0.3
0.5
0
-0.3
2.1
18.2
0
1.1
6.3
0.7
1.3
0.6
0.5
0.6
6.5
7.6
9.5
5
4.5
0
0
0
0

balance-sheet.row.total-non-current-assets

2681.81696.9706.4580.6
377.1
292.1
223.5
135.5
118.2
87.4
53.4
43.4
46.9
46.9
47.5
46.5
39.8
32.1
5.8
22.2
4.8
5.8
11
4.6
5.1
4.3
2.4
1.2
7
8.3
10.4
5.8
5.9
1.1
0.3
0.3
0.3

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

6666.451673.41494.41216.5
1054.3
786.4
550.4
423.9
338.4
205.4
170
153.9
131.6
129.6
136
118
136.2
78.5
61.1
59.2
68.3
89.5
118
121.8
33
38.6
18.5
16.2
14.7
15.4
22.4
25.8
29.9
27.7
12.5
14.7
3.7

balance-sheet.row.account-payables

137.2835.334.832.8
32.2
23.6
20.6
9.4
10.4
7.7
7.7
6.9
6.3
3.8
5.5
9
5.2
3.1
1.1
1.4
1.1
2
2.1
1.6
0.9
2.1
1.3
0.8
0.2
0.4
0.5
0.4
0.3
0
0
0
0

balance-sheet.row.short-term-debt

66.6706675.1
12.3
4.6
0.8
2.5
1.5
1.4
2.1
0.9
0
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-payables

20.021.95.921.6
12.3
4.6
3.2
2.5
1.5
1.4
2.1
0.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0000
0
0
15.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

0000
0
0
-15.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

3---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

235.3176.73.84.9
45.2
41.6
37.7
25.9
20.4
16.5
13.1
11.5
14.1
13
10.8
9.3
7
5.2
3.6
3.3
4.2
5.6
5.6
6.4
4.8
2.9
2
1.5
1.2
0.7
0.7
0.8
0.6
1.3
1.2
1.2
1.4

balance-sheet.row.total-non-current-liabilities

114.1331.635.719.1
11.5
12.2
28.7
8.6
7.5
6.6
5.9
5.2
4.5
3.5
2.4
5
1.2
0.3
0
0
0
0
0.4
0.7
0.2
0.7
0
0
0
3.7
8.7
8.3
7.8
0
0
0
-0.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
16.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

654.2170.1164.7151
117.5
96.9
98.3
55.2
46.8
37.1
32.9
27.6
26.8
21.6
20
24.4
14.1
9
4.9
4.8
6.2
10.2
9.3
8.9
5.9
5.6
3.3
2.3
1.4
4.8
9.9
9.5
8.7
1.3
1.2
1.2
1.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

1.820.50.50.5
0.5
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

4012.96964.5828602.5
399.5
140.5
-47
-99.1
-137.2
-250.9
-258.3
-273.3
-274.8
-263
-244
-212.4
-171.2
-143.3
-113.9
-111.5
-102.1
-84.4
-53.1
-41.7
-31.2
-24.5
-22
-22.8
-23.2
-22.9
-20.9
-17
-11.9
-5.3
-3.4
-1.1
-0.6

balance-sheet.row.accumulated-other-comprehensive-income-loss

-132.56-27.2-11.4-11.2
-14.7
-4.2
-20.6
-14.5
-17.3
-0.7
-3.7
-1.8
0.7
-1
-1.7
5
0.6
-2.1
-0.3
-0.1
-8.6
3.1
3.1
-5.4
-3.9
-2.7
-2.6
-2.3
-2.1
-1.9
-1.6
-1.4
-1.1
-0.8
-0.7
-0.5
-0.3

balance-sheet.row.other-total-stockholders-equity

2130.03565.5512.7473.7
551.7
552.8
519.2
482
445.7
419.6
398.7
400.9
378.4
371.6
361.3
300.7
292.4
214.6
170.1
165.7
172.5
160.4
158.4
159.9
62.1
60.2
39.8
39
38.6
35.4
35
34.7
34.2
32.5
15.4
15.1
3.3

balance-sheet.row.total-stockholders-equity

6012.251503.31329.71065.5
936.9
689.5
452.1
368.8
291.6
168.4
137.1
126.3
104.7
108
116
93.6
122.1
69.5
56.2
54.3
62.1
79.3
108.7
112.9
27.1
33
15.2
13.9
13.3
10.6
12.5
16.3
21.2
26.4
11.3
13.5
2.4

balance-sheet.row.total-liabilities-and-stockholders-equity

6666.451673.41494.41216.5
1054.3
786.4
550.4
423.9
338.4
205.4
170
153.9
131.6
129.6
136
118
136.2
78.5
61.1
59.2
68.3
89.5
118
121.8
33
38.6
18.5
16.2
14.7
15.4
22.4
25.8
29.9
27.7
12.5
14.7
3.7

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

6012.251503.31329.71065.5
936.9
689.5
452.1
368.8
291.6
168.4
137.1
126.3
104.7
108
116
93.6
122.1
69.5
56.2
54.3
62.1
79.3
108.7
112.9
27.1
33
15.2
13.9
13.3
10.6
12.5
16.3
21.2
26.4
11.3
13.5
2.4

balance-sheet.row.total-liabilities-and-total-equity

6666.45---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

3764.04977.7716.7553
392.4
356.8
238.1
164.8
123.6
97.4
78.7
71.2
54.5
53.5
59.1
36.3
5.5
23
36
38.6
9.9
25.7
2
4.5
8.9
23.7
7.7
7.7
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

0000
0
0
16.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-debt

-639.9-132.8-232.7-192.3
-121
-43
-22.7
-48.2
-22.4
-20.9
-9.5
-6
-5.8
-4.8
-1.8
-2
-69.6
-7.8
-7.6
-6.9
-44.6
-45.6
-90.2
-101.7
-9.3
-2.7
-1.6
-2.9
-0.6
-0.5
-0.7
-4.7
-8.1
-24.6
-10.4
-13.3
-2.4

Pinigų srautų ataskaita

Abiomed, Inc. finansiniame kraštovaizdyje per pastarąjį laikotarpį pastebimas pastebimas laisvųjų pinigų srauto pokytis, rodantis NaN pokytį. Bendrovė neseniai išplėtė savo akcinį kapitalą išleisdama NaN, o tai rodo NaN skirtumą, palyginti su praėjusiais metais. Bendrovės investicinė veikla lėmė grynųjų pinigų panaudojimą, kuris ataskaitine valiuta sudarė NaN. Tai NaN pokytis, palyginti su praėjusiais metais. Tuo pačiu laikotarpiu bendrovė užregistravo NaN, NaN ir NaN, kurie yra svarbūs norint suprasti įmonės investavimo ir grąžinimo strategijas. Bendrovės finansinė veikla lėmė grynųjų pinigų panaudojimą NaN, o per metus skirtumas buvo NaN. Be to, bendrovė skyrė NaN dividendams akcininkams išmokėti. Kartu ji ėmėsi kitų finansinių manevrų, vadinamų NaN, kurie taip pat turėjo didelės įtakos jos pinigų srautams šiuo laikotarpiu. Šie komponentai kartu sudaro išsamų įmonės finansinės būklės ir strateginio požiūrio į pinigų srautų valdymą vaizdą.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991

cash-flows.row.net-income

266.76136.5225.5203
259
112.2
52.1
38.1
113.7
7.4
15
1.5
-11.8
-19
-31.6
-40.9
-27.9
-29.4
-2.3
-9.4
-18.2
-21.7
-11.4
-10.5
-6.7
-2.5
0.7
0.5
-0.4
-2
-3.9
-5.1
-6.6

cash-flows.row.depreciation-and-amortization

27.5628.124.120.4
14.1
11
6.2
3.3
2.8
2.5
2.7
4.3
3.9
4.9
5
6.1
3.9
2.7
1.2
1.4
1.7
1.8
3
1.7
1.4
0.9
0.4
0.3
0.4
0.3
0.3
0.6
0.3

cash-flows.row.deferred-income-tax

-13.22.429.433
-7.7
42.6
25.8
22.3
-87.1
0.9
0.8
0.8
1
1
0.7
0.5
0.5
0.3
-0.1
-0.1
-0.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

53.7552.74739.8
54.5
40.4
32.9
29.1
16.5
11.2
9.5
7.8
5.4
5.4
8.8
5.4
5.8
0.4
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-23.26-30.2-17.48
-38.8
-18.9
5.3
-15.6
-4.7
-0.5
-2.8
-11.7
0.5
3.6
-3.5
-8
-2.5
2.8
-4.1
-2.1
-0.2
-0.4
-3.5
1.5
-2.1
0.9
-1.4
-0.3
1.1
-1.8
-0.8
0.9
-0.7

cash-flows.row.account-receivables

-8.515.3-12.15.6
-22
-15.3
-11.6
-10.9
-8
-1.3
-2.6
-5.3
-1.9
2.2
-2.5
-2.8
-1.9
0.3
-2.6
-0.6
1.5
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-36-29.32.5-13.2
-37.2
-15.7
-12.3
-11.5
-7
-0.6
-5.3
-6.2
-1.5
0.9
-1.6
-11.1
-4.1
-0.2
-1.2
0.2
1.4
-0.7
-0.1
-0.7
-0.6
-0.9
-0.2
-0.2
0.8
-0.7
-0.7
0.3
-0.1

cash-flows.row.account-payables

8.480.62.62.6
8
4.4
7.6
-2.6
3.4
-0.1
1.2
0.3
2.5
-1.4
-2.4
3.2
1.6
1.3
-0.2
0.3
-0.9
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

12.77-6.8-10.513.1
12.4
7.6
21.6
9.4
6.8
1.5
3.9
-0.5
1.4
1.8
3
2.6
2
1.4
-0.2
-2
-2.1
0.3
-3.4
2.1
-1.5
1.8
-1.2
0
0.3
-1.1
-0.1
0.6
-0.6

cash-flows.row.other-non-cash-items

-60.6395.8-3410.7
-28.8
5.3
-7.2
-0.4
2.1
2.1
1.2
1
2.5
-3.1
2.2
8.1
0.3
13.9
0.1
0
0.5
0.3
0
0
0
0
0
0
-0.2
0.1
0.1
0.2
3

cash-flows.row.net-cash-provided-by-operating-activities

250.98000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-33.76-35.8-53.4-44
-44
-55.9
-50.4
-15.6
-5.2
-2.8
-2.8
-1.7
-1.8
-1.8
-3.8
-3.8
-2.4
-3.1
-0.7
-0.4
-0.8
-1.6
-2.6
-1.4
-1.6
-16
-1.6
-0.3
-0.1
-0.2
-0.3
-0.1
-0.2

cash-flows.row.acquisitions-net

0-82.8-52.20
0
0
0
0
-15.7
0
0
1.7
3.8
4.6
5.6
0
0
-2.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

-745.81-805.9-582.3-632.2
-404.3
-331.8
-281.4
-261.7
-100.5
-87.8
-49.4
-24.5
-8
-11.9
-60.2
-66.4
-17.7
-29
-39.5
-39
-14.6
-38
-27
-8.3
-25.5
0
0
0
-1.3
-2.9
-4.3
0
0

cash-flows.row.sales-maturities-of-investments

616.66543.5464.5550.8
331.9
206.9
205.5
219.6
71.5
68.3
42
8.8
7
17.8
37.1
34.5
35.2
42
42.2
10.2
30.4
14.4
29.4
12.7
40.4
0
0
2.7
0
6.2
4.9
0
5.5

cash-flows.row.other-investing-activites

0000
0
0
0
0
0
0
0
-1.7
-3.4
0
-5.6
-5.1
0
0
0
0
-0.1
0
0
0
0
-2.5
0
-0.8
0.7
0
0.1
0
-0.1

cash-flows.row.net-cash-used-for-investing-activites

-162.91-381-223.3-125.5
-116.5
-180.8
-126.3
-57.7
-49.9
-22.3
-10.3
-17.5
-2.4
8.8
-26.8
-40.9
15.1
7.4
1.9
-29.2
14.8
-25.2
-0.1
3.1
13.3
-18.5
-1.6
1.6
-0.7
3.1
0.4
-0.1
5.2

cash-flows.row.debt-repayment

0000
0
-0.5
-0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

10.357.25.55.1
3.1
2.4
1.7
1.1
0.8
-0.3
-0.3
0.4
0.3
0.3
42.2
3.9
66.6
2.2
4.1
1.6
0.3
1
0.9
96.3
0.8
20.3
0.5
0.1
0
0.1
0.1
0.1
1.4

cash-flows.row.common-stock-repurchased

-126.620-11.3-84.9
0
0
0
0
0
-0.4
-15.3
0
0
0
0
-1.9
-0.1
-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

-19.26-9.4-2.2-37.9
-58.8
-11
2.6
6
8.7
10.3
3.7
14.3
1.1
0.6
4
0
0
0
0
0
-0.1
-0.5
-0.2
0.6
0
0
0
0
0
0
-0.1
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

-135.53-2.2-8.1-117.7
-55.8
-9.1
3.9
7.2
9.5
9.6
-11.8
14.7
1.4
1
46.2
2.1
66.6
2.1
4.1
1.6
0.3
0.5
0.6
96.9
0.8
20.3
0.5
0.1
0
0.1
0
0.1
1.4

cash-flows.row.effect-of-forex-changes-on-cash

-12.08-2.1-2.8-0.4
-1.9
1.3
-1.8
-0.4
-1.5
0.6
-0.9
-0.7
0.4
0.6
-1.4
0.1
0
0.1
-0.1
0.1
0
0
0
0
0
0
0
0
0
0.3
0
3.5
-1.2

cash-flows.row.net-change-in-cash

-59.55-99.940.471.3
78
3.9
-9.2
25.8
1.5
11.5
3.5
0.2
1
3
-0.3
-67.6
61.8
0.2
0.8
-37.7
-1.1
-44.8
-11.5
92.6
6.6
1.1
-1.3
2.3
0.2
0.1
-3.9
0.1
1.4

cash-flows.row.cash-at-end-of-period

639.9132.8232.7192.3
121
43
39
48.2
22.4
20.9
9.5
6
5.8
4.8
1.8
2
69.6
7.8
7.6
6.9
44.6
45.7
90.5
101.9
9.3
2.7
1.6
2.9
0.7
0.8
0.8
8.1
6.8

cash-flows.row.cash-at-beginning-of-period

699.45232.7192.3121
43
39
48.2
22.4
20.9
9.5
6
5.8
4.8
1.8
2
69.6
7.8
7.6
6.8
44.6
45.7
90.5
101.9
9.3
2.7
1.6
2.9
0.6
0.5
0.7
4.7
8
5.4

cash-flows.row.operating-cash-flow

250.98285.4274.6314.9
252.2
192.5
115.1
76.8
43.3
23.5
26.4
3.6
1.6
-7.4
-18.3
-28.9
-19.8
-9.3
-5.2
-10.1
-16.2
-20.1
-12
-7.3
-7.4
-0.7
-0.2
0.6
0.9
-3.4
-4.3
-3.4
-4

cash-flows.row.capital-expenditure

-33.76-35.8-53.4-44
-44
-55.9
-50.4
-15.6
-5.2
-2.8
-2.8
-1.7
-1.8
-1.8
-3.8
-3.8
-2.4
-3.1
-0.7
-0.4
-0.8
-1.6
-2.6
-1.4
-1.6
-16
-1.6
-0.3
-0.1
-0.2
-0.3
-0.1
-0.2

cash-flows.row.free-cash-flow

217.22249.6221.2270.9
208.2
136.7
64.7
61.2
38.1
20.7
23.6
1.9
-0.2
-9.2
-22.1
-32.7
-22.2
-12.4
-5.9
-10.6
-17
-21.7
-14.5
-8.7
-9
-16.7
-1.8
0.2
0.8
-3.6
-4.6
-3.5
-4.2

Pajamų ataskaitos eilutė

Abiomed, Inc. pajamos, palyginti su ankstesniu laikotarpiu, pasikeitė NaN%. Pranešama, kad bendrasis ABMD pelnas yra NaN. Bendrovės veiklos sąnaudos yra NaN, palyginti su praėjusiais metais, jos pakito NaN%. Nusidėvėjimo ir amortizacijos sąnaudos yra NaN, o tai yra NaN% pokytis nuo praėjusio ataskaitinio laikotarpio. Pranešama, kad veiklos išlaidos yra NaN, kurios rodo NaN% pokytį per metus. Pardavimo ir rinkodaros išlaidos yra NaN, kuris yra NaN% рokytis, palyginti su praėjusiais metais. Naujausiais duomenimis pagrįsta EBITDA yra NaN, o tai reiškia NaN% augimą per metus. Veiklos pajamos yra NaN, kurios rodo NaN% pokytį, palyginti su praėjusiais metais. Grynųjų pajamų pokytis yra NaN%. Praėjusių metų grynosios pajamos buvo NaN.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990198919881987

income-statement-row.row.total-revenue

1074.11031.8847.5840.9
769.4
593.7
445.3
329.5
230.3
183.6
158.1
126.4
101.2
85.7
73.2
58.9
50.6
43.7
38.2
25.7
23.3
26.9
24.9
22.5
22.1
22.4
16.5
12.8
9.2
6.7
3.4
2.7
2
3
2.9
4.2
4.7

income-statement-row.row.cost-of-revenue

200.59188.2161.9151.3
129.6
98.6
70.6
50.4
39.9
37.3
31.6
24.5
22
22.5
20.4
15.1
12
11.7
9.4
7.6
7.5
7.9
7.4
5.9
6.8
6.5
5.4
3.9
2.9
1.9
3
2
1.3
1
1.1
0.2
3.7

income-statement-row.row.gross-profit

873.51843.6685.6689.6
639.9
495.2
374.7
279.1
190.4
146.3
126.5
101.9
79.2
63.2
52.8
43.9
38.6
32
28.9
18.1
15.8
18.9
17.5
16.6
15.3
15.9
11.1
8.9
6.3
4.8
0.4
0.7
0.7
2
1.8
4
1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

167.22---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-7.58051.9-4.6
30.4
-0.4
-0.3
0.3
-0.1
0
0.3
1.5
1.4
1.5
1.6
2.8
1.6
1.3
13.2
13.6
20.4
0
0
0
0
-1.2
0
0
0.4
0.3
0.3
0.6
0.3
0.2
0.2
0.2
0.2

income-statement-row.row.operating-expenses

619.4586.9456.1440.4
415.1
338
284.5
214
161.7
138
110
100.3
90.4
88.3
82.3
80.4
66.3
62.3
32.1
28.4
35.3
43.6
35.1
28.2
23.2
16.9
10.9
9
7.2
7.1
4.9
7
9.1
5.4
5
5.3
1.1

income-statement-row.row.cost-and-expenses

819.99775618591.7
544.6
436.6
355.2
264.4
201.6
175.3
141.6
124.9
112.3
110.8
102.7
95.4
78.4
74
41.5
36
42.8
51.5
42.5
34.1
30
23.4
16.3
12.9
10.1
9
7.9
9
10.4
6.4
6.1
5.5
4.8

income-statement-row.row.interest-income

94.2449.800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

94.2449.800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

87.06-182.158.77.6
38.5
3.3
1.2
0.7
0.1
0.2
0.3
1
0.3
6.7
-1.3
-5.1
0.3
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0.4
0.4
0.6
1.2
1.7
1.5
0.9
0.7
0.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-7.58051.9-4.6
30.4
-0.4
-0.3
0.3
-0.1
0
0.3
1.5
1.4
1.5
1.6
2.8
1.6
1.3
13.2
13.6
20.4
0
0
0
0
-1.2
0
0
0.4
0.3
0.3
0.6
0.3
0.2
0.2
0.2
0.2

income-statement-row.row.total-operating-expenses

87.06-182.158.77.6
38.5
3.3
1.2
0.7
0.1
0.2
0.3
1
0.3
6.7
-1.3
-5.1
0.3
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0.4
0.4
0.6
1.2
1.7
1.5
0.9
0.7
0.2

income-statement-row.row.interest-expense

94.2449.800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

30.4828.117.48.3
14.1
11
6.2
3.3
2.8
2.5
2.7
4.3
3.9
4.9
5
6.1
3.9
2.7
1.2
1.4
1.7
1.8
3
1.7
1.4
0.9
0.4
0.3
0.4
0.3
0.3
0.6
0.3
0.2
0.2
0.2
0.2

income-statement-row.row.ebitda-caps

284.19---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

253.61372.7229.6249.2
224.8
157.1
90.1
65.1
28.7
8.4
16.5
1.5
-11.2
-25.1
-29.5
-36.5
-28.5
-30.3
-3.3
-10.3
-19.5
-24.6
-17.6
-11.6
-7.9
-1
0.2
0
-0.9
-2.3
-4.5
-6.3
-8.4
-3.4
-3.2
-1.3
-0.1

income-statement-row.row.income-before-tax

341.16190.6288.2256.8
263.4
160.4
91.3
65.8
28.8
8.5
16.9
2.5
-10.9
-18.4
-30.8
-40.4
-27.4
-29.1
-2.3
-9.4
-18.2
0
0
0
0
0
0
0
-0.5
-1.9
-3.9
-5.1
-6.7
-1.9
-2.3
-0.6
0.1

income-statement-row.row.income-tax-expense

74.454.162.753.8
4.3
48.3
39.2
27.7
-84.9
1.2
1.8
1
0.9
0.7
0.8
0.5
0.5
0.4
0.1
0.2
0.2
-2.9
-6.2
-1.1
-1.2
1.5
-0.5
-0.5
-0.5
0.4
0.6
1.2
1.7
1.5
0.9
0.7
0.2

income-statement-row.row.net-income

266.76136.5225.5203
259
112.2
52.1
38.1
113.7
7.4
15
1.5
-11.8
-19
-31.6
-40.9
-27.9
-29.4
-2.3
-9.4
-18.2
-21.7
-11.4
-10.5
-6.7
-2.5
0.7
0.5
-0.4
-2
-3.9
-5.1
-6.6
-1.9
-2.2
-0.6
0.1
Panašios akcijos
Jus taip pat gali dominti:
EAR
Eargo, Inc..
2.58 USD
NASDAQ
ELEAF
EL.En. S.p.A..
9.8 USD
PNK
FORZ
Forza Innovations Inc..
0.0001 USD
PNK
SILK
Silk Road Medical, Inc.
18.97 USD
NASDAQ
UNIVPHOTO.NS
Universus Photo Imagings Limited.
391 INR
NSE
SGMD.V
Salona Global Medical Device Corporation.
0.22 CAD
TSX
HTL.V
Hamilton Thorne Ltd..
1.45 CAD
TSX

Dažnai užduodami klausimai

Kas yra Abiomed, Inc. (ABMD) bendras turtas?

Abiomed, Inc. (ABMD) bendras turtas yra 1673393000.000.

Kokios yra įmonės metinės pajamos?

Metinės pajamos yra 543070000.000.

Kokia yra įmonės pelno marža?

Įmonės pelno marža yra 0.818.

Koks yra įmonės laisvųjų pinigų srautas?

Laisvųjų pinigų srautas yra 5.493.

Kokia yra įmonės grynojo pelno marža?

Grynojo pelno marža yra 0.132.

Kokios yra bendros įmonės pajamos?

Bendrosios pajamos yra 0.361.

Kas yra Abiomed, Inc. (ABMD) grynasis pelnas (grynosios pajamos)?

Grynasis pelnas (grynosios pajamos) yra 136505000.000.

Kokia yra bendra įmonės skola?

Bendra skola yra 0.000.

Koks yra veiklos sąnaudų skaičius?

Veiklos sąnaudos yra 586889000.000.

Koks yra įmonės grynųjų pinigų skaičius?

Įmonės grynieji pinigai yra 182335000.000.